Gregory L Kedderis

The Impact of Cytochrome P450 2E1‐Dependent Metabolic Variance on a Risk‐Relevant Pharmacokinetic Outcome in Humans

Tony Cox, John C Lipscomb, Linda K Teuschler, 2003, Risk analysis : an official publication of the Society for Risk Analysis.

Priorities for development of research methods in occupational cancer.

Paul A Schulte, Nathaniel Rothman, Andrew F Olshan, 2002, Environmental health perspectives.

Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment

John C Lipscomb, G. L. Kedderis, J. Lipscomb, 2001, Toxicology and industrial health.

Incorporation of Pharmacokinetic and Pharmacodynamic Data into Risk Assessments

Kannan Krishnan, John C Lipscomb, Harvey Clewell, 2004, Toxicology mechanisms and methods.

Physiologically based pharmacokinetic model parameter estimation and sensitivity and variability analyses for acrylonitrile disposition in humans.

Lisa M Sweeney, G. L. Kedderis, L. Sweeney, 2003, Toxicological sciences : an official journal of the Society of Toxicology.

Kinetics of arsenic methylation by freshly isolated B6C3F1 mouse hepatocytes.

Janice W Yager, G. L. Kedderis, T. Goldsworthy, 2006, Chemico-biological interactions.